{"id":"https://openalex.org/W2010633193","doi":"https://doi.org/10.1177/00912709922008236","title":"Buprenorphine Pharmacokinetics: Relative Bioavailability of Sublingual Tablet and Liquid Formulations","display_name":"Buprenorphine Pharmacokinetics: Relative Bioavailability of Sublingual Tablet and Liquid Formulations","alternate_titles":[],"publication_year":1999,"publication_date":"1999-06-01","ids":{"openalex":"https://openalex.org/W2010633193","doi":"https://doi.org/10.1177/00912709922008236","mag":"2010633193","pmid":"https://pubmed.ncbi.nlm.nih.gov/10354966"},"language":"en","primary_location":{"id":"doi:10.1177/00912709922008236","doi":"https://doi.org/10.1177/00912709922008236","is_oa":false,"landing_page_url":"https://doi.org/10.1177/00912709922008236","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2010633193"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108677112","display_name":"Rajneesh P. Nath","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2802195347","display_name":"Langley Porter Psychiatric Hospital and Clinics","ror":"https://ror.org/014gzk937","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802195347"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rajneesh P. Nath","raw_affiliation_strings":["Drug Dependence Research Center, Langley Porter Psychiatric Institute, University of California, San Francisco 94143-0984, USA","Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Dependence Research Center, Langley Porter Psychiatric Institute, University of California, San Francisco 94143-0984, USA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I2802195347"]},{"raw_affiliation_string":"Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I2802195347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111542569","display_name":"Robert A. Upton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2802195347","display_name":"Langley Porter Psychiatric Hospital and Clinics","ror":"https://ror.org/014gzk937","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802195347"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert A. Upton","raw_affiliation_strings":["Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I2802195347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111986299","display_name":"E. Thomas Everhart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2802195347","display_name":"Langley Porter Psychiatric Hospital and Clinics","ror":"https://ror.org/014gzk937","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802195347"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Thomas Everhart","raw_affiliation_strings":["Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I2802195347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112493644","display_name":"Polly Cheung","orcid":"https://orcid.org/0000-0002-6297-7779","observed_orcids":["https://orcid.org/0000-0002-6297-7779"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2802195347","display_name":"Langley Porter Psychiatric Hospital and Clinics","ror":"https://ror.org/014gzk937","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802195347"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Polly Cheung","raw_affiliation_strings":["Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I2802195347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068713194","display_name":"Peter J. Shwonek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2802195347","display_name":"Langley Porter Psychiatric Hospital and Clinics","ror":"https://ror.org/014gzk937","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802195347"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Shwonek","raw_affiliation_strings":["Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I2802195347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111529150","display_name":"Reese T. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2802195347","display_name":"Langley Porter Psychiatric Hospital and Clinics","ror":"https://ror.org/014gzk937","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802195347"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Reese T. Jones","raw_affiliation_strings":["Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I2802195347"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026176242","display_name":"John E. Mendelson","orcid":"https://orcid.org/0000-0002-9596-8377","observed_orcids":["https://orcid.org/0000-0002-9596-8377"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2802195347","display_name":"Langley Porter Psychiatric Hospital and Clinics","ror":"https://ror.org/014gzk937","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802195347"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John E. Mendelson","raw_affiliation_strings":["Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Dependence Research Center, Langley Porter Psychiatric Institute, and the Department of Biopharmaceutical Sciences, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I2802195347"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111529150"],"corresponding_institution_ids":["https://openalex.org/I180670191","https://openalex.org/I2802195347"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":6.798,"has_fulltext":false,"cited_by_count":135,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96649303,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"39","issue":"6","first_page":"619","last_page":"623"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.6151999831199646,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.6151999831199646,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.15369999408721924,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.09650000184774399,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8930000066757202},{"id":"https://openalex.org/keywords/relative-bioavailability","display_name":"relative bioavailability","score":0.9269999861717224},{"id":"https://openalex.org/keywords/sublingual-administration","display_name":"sublingual administration","score":0.8330000042915344},{"id":"https://openalex.org/keywords/sublingual-tablets","display_name":"sublingual tablets","score":0.8100000023841858},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.8100000023841858},{"id":"https://openalex.org/keywords/salivary-ph","display_name":"salivary pH","score":0.8109999895095825},{"id":"https://openalex.org/keywords/drug-dissolution-rate","display_name":"drug dissolution rate","score":0.6299999952316284},{"id":"https://openalex.org/keywords/plasma-concentration-time-curve","display_name":"plasma concentration-time curve","score":0.8100000023841858}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.9470565915107727},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.8267282247543335},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7071382999420166},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5712953209877014},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.5691173076629639},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5461843609809875},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5326364040374756},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.49425816535949707},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47197848558425903},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.4137711524963379},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28291401267051697},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.13981002569198608},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000286","descriptor_name":"Administration, Sublingual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019999","descriptor_name":"Pharmaceutical Solutions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/00912709922008236","doi":"https://doi.org/10.1177/00912709922008236","is_oa":false,"landing_page_url":"https://doi.org/10.1177/00912709922008236","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:10354966","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10354966","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2672458063","display_name":"DRUG DEPENDENCE CLINICAL RESEARCH PROGRAM","funder_award_id":"P50DA001696","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G2702568274","display_name":null,"funder_award_id":"N01-DA48306","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5850346315","display_name":null,"funder_award_id":"DA00053","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1966282663","https://openalex.org/W1967044871","https://openalex.org/W1979348206","https://openalex.org/W1980315117","https://openalex.org/W1984373099","https://openalex.org/W2009257194","https://openalex.org/W2014229964","https://openalex.org/W2050443628","https://openalex.org/W2055760308","https://openalex.org/W2061161214","https://openalex.org/W2072645587","https://openalex.org/W2120668524","https://openalex.org/W2159011576","https://openalex.org/W2163193375","https://openalex.org/W2318728167","https://openalex.org/W4298217597","https://openalex.org/W4300702859"],"related_works":["https://openalex.org/W2093376565","https://openalex.org/W2017450429","https://openalex.org/W1979348206","https://openalex.org/W2090989559","https://openalex.org/W1969058086","https://openalex.org/W2041288682","https://openalex.org/W2316066359","https://openalex.org/W2094830754","https://openalex.org/W2593411235","https://openalex.org/W2053162682"],"abstract_inverted_index":{"Buprenorphine":[0],"is":[1],"an":[2],"effective":[3],"new":[4],"treatment":[5],"for":[6],"opiate":[7],"dependence.":[8],"This":[9],"study":[10],"compared":[11],"the":[12,86,93,105],"bioavailability":[13,84,103],"of":[14,40,81],"buprenorphine":[15,41],"from":[16,21,85,92,104],"a":[17,22,55],"tablet":[18,49,87,106],"to":[19,110],"that":[20,91],"reference":[23],"solution.":[24],"Six":[25],"men":[26],"experienced":[27],"with,":[28],"but":[29],"not":[30,97],"dependent":[31],"on,":[32],"opiates":[33],"(DSM-III-R)":[34],"were":[35,61,73,77],"each":[36],"administered":[37],"7.7":[38],"mg":[39,47],"in":[42,48,54],"liquid":[43,94],"form":[44,50],"and":[45,70,95],"8":[46],"1":[51],"week":[52],"apart":[53],"balanced":[56],"crossover":[57],"design.":[58],"Plasma":[59],"levels":[60],"measured":[62],"by":[63,79,99],"electron":[64],"capture":[65],"capillary":[66],"gas":[67],"chromatography":[68],"(GC),":[69],"concentration-time":[71],"curves":[72],"constructed.":[74],"Pharmacokinetic":[75],"data":[76],"analyzed":[78],"analysis":[80],"variance.":[82],"The":[83],"was":[88,96],"approximately":[89],"50%":[90],"affected":[98],"saliva":[100],"pH.":[101],"Lower":[102],"may":[107],"be":[108],"due":[109],"slow":[111],"dissolution.":[112]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2010633193","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
